466 related articles for article (PubMed ID: 35159157)
21. Tumor-Derived Extracellular Vesicles Induce CCL18 Production by Mast Cells: A Possible Link to Angiogenesis.
Shefler I; Salamon P; Zitman-Gal T; Mekori YA
Cells; 2022 Jan; 11(3):. PubMed ID: 35159163
[TBL] [Abstract][Full Text] [Related]
22. Mast Cells as Drivers of Disease and Therapeutic Targets.
Siebenhaar F; Redegeld FA; Bischoff SC; Gibbs BF; Maurer M
Trends Immunol; 2018 Feb; 39(2):151-162. PubMed ID: 29196147
[TBL] [Abstract][Full Text] [Related]
23. Mast Cells in Liver Fibrogenesis.
Weiskirchen R; Meurer SK; Liedtke C; Huber M
Cells; 2019 Nov; 8(11):. PubMed ID: 31766207
[TBL] [Abstract][Full Text] [Related]
24. Isolation of Mature (Peritoneum-Derived) Mast Cells and Immature (Bone Marrow-Derived) Mast Cell Precursors from Mice.
Meurer SK; Neß M; Weiskirchen S; Kim P; Tag CG; Kauffmann M; Huber M; Weiskirchen R
PLoS One; 2016; 11(6):e0158104. PubMed ID: 27337047
[TBL] [Abstract][Full Text] [Related]
25. Human Tumor Targeted Cytotoxic Mast Cells for Cancer Immunotherapy.
Fereydouni M; Ahani E; Desai P; Motaghed M; Dellinger A; Metcalfe DD; Yin Y; Lee SH; Kafri T; Bhatt AP; Dellinger K; Kepley CL
Front Oncol; 2022; 12():871390. PubMed ID: 35574362
[TBL] [Abstract][Full Text] [Related]
26. Role of mast cells activation in the tumor immune microenvironment and immunotherapy of cancers.
Guo X; Sun M; Yang P; Meng X; Liu R
Eur J Pharmacol; 2023 Dec; 960():176103. PubMed ID: 37852570
[TBL] [Abstract][Full Text] [Related]
27. Role of Mast Cells in Shaping the Tumor Microenvironment.
Komi DEA; Redegeld FA
Clin Rev Allergy Immunol; 2020 Jun; 58(3):313-325. PubMed ID: 31256327
[TBL] [Abstract][Full Text] [Related]
28. Tumor-Associated Mast Cells in Urothelial Bladder Cancer: Optimizing Immuno-Oncology.
Choi HW; Naskar M; Seo HK; Lee HW
Biomedicines; 2021 Oct; 9(11):. PubMed ID: 34829729
[TBL] [Abstract][Full Text] [Related]
29. Mast cell accumulation in glioblastoma with a potential role for stem cell factor and chemokine CXCL12.
Põlajeva J; Sjösten AM; Lager N; Kastemar M; Waern I; Alafuzoff I; Smits A; Westermark B; Pejler G; Uhrbom L; Tchougounova E
PLoS One; 2011; 6(9):e25222. PubMed ID: 21949886
[TBL] [Abstract][Full Text] [Related]
30. Immunosurveillance function of human mast cell?
Ozdemir O
World J Gastroenterol; 2005 Nov; 11(44):7054-6. PubMed ID: 16437618
[TBL] [Abstract][Full Text] [Related]
31. Mast cells in abdominal aortic aneurysms.
Shi GP; Lindholt JS
Curr Vasc Pharmacol; 2013 May; 11(3):314-26. PubMed ID: 22724485
[TBL] [Abstract][Full Text] [Related]
32. Mast Cell Serotonin Immunoregulatory Effects Impacting on Neuronal Function: Implications for Neurodegenerative and Psychiatric Disorders.
Conti P; Shaik-Dasthagirisaheb YB
Neurotox Res; 2015 Aug; 28(2):147-53. PubMed ID: 26038194
[TBL] [Abstract][Full Text] [Related]
33. Pivotal role of mast cells in pruritogenesis in patients with myeloproliferative disorders.
Ishii T; Wang J; Zhang W; Mascarenhas J; Hoffman R; Dai Y; Wisch N; Xu M
Blood; 2009 Jun; 113(23):5942-50. PubMed ID: 19196660
[TBL] [Abstract][Full Text] [Related]
34. Mast cell-T cell axis alters development of colitis-dependent and colitis-independent colorectal tumours: potential for therapeutically targeting via mast cell inhibition.
Sakita JY; Elias-Oliveira J; Carlos D; de Souza Santos E; Almeida LY; Malta TM; Brunaldi MO; Albuquerque S; Araújo Silva CL; Andrade MV; Bonato VLD; Garcia SB; Cunha FQ; Cebinelli GCM; Martins RB; Matthews J; Colli L; Martin FL; Uyemura SA; Kannen V
J Immunother Cancer; 2022 Oct; 10(10):. PubMed ID: 36220303
[TBL] [Abstract][Full Text] [Related]
35. Mast Cells Granular Contents Are Crucial for Deep Vein Thrombosis in Mice.
Ponomaryov T; Payne H; Fabritz L; Wagner DD; Brill A
Circ Res; 2017 Sep; 121(8):941-950. PubMed ID: 28739590
[TBL] [Abstract][Full Text] [Related]
36. Mast Cells Localize in Hypoxic Zones of Tumors and Secrete CCL-2 under Hypoxia through Activation of L-Type Calcium Channels.
Ramírez-Moreno IG; Ibarra-Sánchez A; Castillo-Arellano JI; Blank U; González-Espinosa C
J Immunol; 2020 Feb; 204(4):1056-1068. PubMed ID: 31900336
[TBL] [Abstract][Full Text] [Related]
37. Glioma-derived plasminogen activator inhibitor-1 (PAI-1) regulates the recruitment of LRP1 positive mast cells.
Roy A; Coum A; Marinescu VD; Põlajeva J; Smits A; Nelander S; Uhrbom L; Westermark B; Forsberg-Nilsson K; Pontén F; Tchougounova E
Oncotarget; 2015 Sep; 6(27):23647-61. PubMed ID: 26164207
[TBL] [Abstract][Full Text] [Related]
38. Ultrastructural features of tumor-associated mast cells in parasympathetic paragangliomas (chemodectomas) of the neck.
Chekmaryova I; Kalinin D; Kostin A; Buchwalow I; Tiemann M; Elieh-Ali-Komi D; Atiakshin D
Microsc Res Tech; 2024 Jun; 87(6):1373-1383. PubMed ID: 38380731
[TBL] [Abstract][Full Text] [Related]
39. Mast cells promote proliferation and migration and inhibit differentiation of mesenchymal stem cells through PDGF.
Nazari M; Ni NC; Lüdke A; Li SH; Guo J; Weisel RD; Li RK
J Mol Cell Cardiol; 2016 May; 94():32-42. PubMed ID: 26996757
[TBL] [Abstract][Full Text] [Related]
40. Glioma-derived macrophage migration inhibitory factor (MIF) promotes mast cell recruitment in a STAT5-dependent manner.
Põlajeva J; Bergström T; Edqvist PH; Lundequist A; Sjösten A; Nilsson G; Smits A; Bergqvist M; Pontén F; Westermark B; Pejler G; Forsberg Nilsson K; Tchougounova E
Mol Oncol; 2014 Feb; 8(1):50-8. PubMed ID: 24091309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
